Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR-α/δ) agonist indicated for the treatment of primary biliary cholangitis and investigated for metabolic liver conditions such as non-alcoholic… Read more










Elafibranor is a dual peroxisome proliferator-activated receptor (PPAR-α/δ) agonist indicated for the treatment of primary biliary cholangitis and investigated for metabolic liver conditions such as non-alcoholic steatohepatitis. Analytical laboratories require precise reference standards to monitor the drug throughout development and manufacturing. This category offers a comprehensive selection of Elafibranor impurities, including degradation products and structurally related analogues, alongside stable isotope labelled compounds. These materials are critical for accurate impurity profiling, allowing researchers to identify and quantify byproducts formed during synthesis or storage, such as oxidation or hydrolysis products. By incorporating these reference materials into analytical testing workflows, laboratories can conduct rigorous method validation and ensure consistent quality control in compliance with established regulatory guidelines. Stable isotope labelled analogues serve as essential internal standards for reliable quantification during mass spectrometry applications.